ProfileGDS5822 / ILMN_1227837
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 22% 30% 6% 12% 27% 1% 2% 6% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 113.322
GSM1276600PDAC Late Ablation Control 217.430
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 17.56
GSM1276603PDAC Late Ablation 29.112
GSM1276604PDAC Late Ablation 314.527
GSM1303940PDAC Late Ablation_anti-CTLA4 12.41
GSM1303941PDAC Late Ablation_anti-CTLA4 22.42
GSM1303942PDAC Late Ablation_anti-CTLA4 34.46